Mumbai, May 14, 2024 - Mukesh Ambani, the Chairman of Reliance Industries, is eyeing a foray into the lucrative diagnostic healthcare sector in India. With a real-time net worth soaring at Rs 920340 crore, according to Forbes, Ambani's ambition extends beyond the realms of telecom and retail, with his sights now set on healthcare.
.jpeg)
Reliance Retail Ventures, a subsidiary of Reliance Group, is reportedly in talks to acquire a majority stake in a diagnostic services company with an investment ranging from Rs 1000-3000 crore. Sources suggest that the conglomerate is actively seeking a player with a pan-India presence, as reported by HinduBusinessline.
This move comes as no surprise given Ambani's penchant for diversification and expansion. With his children, Akash, Anant, and Isha Ambani, already holding key positions in various subsidiaries of the group, Reliance Industries appears poised to make significant strides in the healthcare arena.
Reliance's venture into diagnostics isn't entirely unprecedented. The conglomerate had previously ventured into the healthcare space through its acquisition of Netmeds, an online pharmacy, for Rs 620 crore in 2020. Netmeds, which has since expanded to over 1000 offline outlets, currently offers pathology services through partnerships with companies like Thyrocare and Healthians.
However, Reliance's latest move signals a strategic shift towards establishing its own diagnostic company, equipped with a vast network of physical laboratories across the country. This move aligns with the conglomerate's overarching goal of vertical integration and market dominance.
As India's largest company by market capitalization, Reliance Industries under Mukesh Ambani's stewardship continues to chart new territories and redefine industry landscapes. With the potential entry into the USD 150 billion diagnostic healthcare segment, the conglomerate aims to carve out a substantial presence in yet another critical sector of the Indian economy.
The proposed acquisition underscores Reliance's commitment to innovation, growth, and delivering comprehensive solutions to meet the evolving needs of consumers in India and beyond. As the healthcare sector undergoes rapid transformation and digitization, Reliance's entry into diagnostics is poised to reshape the industry dynamics, offering new avenues for growth and development.